...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >APPLICATION OF QUALITY BY DESIGN APPROACH FOR THE OPTIMIZATION OF ORODISPERSIBLE FILM FORMULATION
【24h】

APPLICATION OF QUALITY BY DESIGN APPROACH FOR THE OPTIMIZATION OF ORODISPERSIBLE FILM FORMULATION

机译:通过设计方法将质量应用于可乳化薄膜配方的优化

获取原文

摘要

Objective: The present study was done to understand the effect of formulation variables on the quality of orodispersible films using quality by design (QbD) approach as mentioned in ICH Q8 (R2) guideline. Methods: A definitive screening design of experiments (DoE) was used to identify and classify the critical formulation variables affecting critical quality attributes (CQA) using 2×2 factorial design. Based on prescreening study, the critical formulation variables, i.e. concentration of film-forming polymer and plasticizers (propylene glycol and polyethylene glycol 400 [PEG 400]) were kept in the range of 1.5–2.5% w/w and 0.5–1% v/v, respectively. A total of eight laboratory-scale formulations were prepared which were provided by DoE using solvent casting method. These batches were evaluated for CQA’s, i.e. mechanical properties such as folding endurance (FD) and disintegration time (DT). Data were analyzed for elucidating interactions between two variables and for providing a predictive model for the process. Finally, the drug was incorporated into optimized batches, and these were evaluated for in vitro dissolution study in simulated saliva (pH 6.8) as well as their mechanical properties. Results: The results suggested that the concentration of film-forming polymer and plasticizer was critical to manufacture orodispersible film with desired CQA, i.e. mechanical property (FD [150 folds]) and DT (60 s). The percent drug release, FD, and DT of optimized Formulation I (hydroxypropyl methylcellulose [HPMC] E5 (2%) and propylene glycol [0.15 mL]) were found to be 82.13%±0.260 (in 15 min), 164±2, and 49±1.5 s, respectively, and for optimized Formulation II (HPMC E5 [2%] and PEG 400 [0.15 mL]) was found to be 64.26%±2.026 (in 15 min) and 218±6 and 55±4 s, respectively. Conclusion: From the results, it has been found that the percentage drug release of naratriptan hydrochloride containing propylene glycol as a plasticizer was greater than the formulation containing PEG 400 as plasticizer. From this, we concluded that QbD is very much useful approach to get an optimized formulation in an economic and faster way in comparison to traditional method (hit and trail methods). The futuristic application of the film will involve the management of an acute migraine.
机译:目的:进行本研究是为了了解ICH Q8(R2)指南中提到的使用质量设计(QbD)方法对配方变量对口分散膜质量的影响。方法:使用2×2因子设计,使用确定性的实验筛选设计(DoE)对影响关键质量属性(CQA)的关键配方变量进行识别和分类。根据预筛选研究,关键的配方变量,即成膜聚合物和增塑剂(丙二醇和聚乙二醇400 [PEG 400])的浓度保持在1.5–2.5%w / w和0.5–1%v的范围内/ v。美国能源部使用溶剂浇铸法制备了总共八种实验室规模的制剂。对这些批次进行了CQA评估,即机械性能,例如耐折性(FD)和崩解时间(DT)。分析数据以阐明两个变量之间的相互作用并为该过程提供预测模型。最后,将该药物掺入优化的批次中,并对其进行评估以用于模拟唾液(pH 6.8)中的体外溶出度研究及其机械性能。结果:结果表明,成膜聚合物和增塑剂的浓度对于制造具有所需CQA(即机械性能(FD [> 150倍])和DT(<60 s)的口腔分散膜至关重要。发现优化配方I(羟丙基甲基纤维素[HPMC] E5(2%)和丙二醇[0.15 mL])的药物释放百分比,FD和DT为82.13%±0.260(在15分钟内),164±2,对于优化的配方II(HPMC E5 [2%]和PEG 400 [0.15 mL]),分别为49±1.5 s和218±6和55±4 s,分别为64.26%±2.026(在15分钟内) , 分别。结论:从结果中发现,含有丙二醇作为增塑剂的盐酸那拉曲普坦的药物释放百分比大于含有PEG 400作为增塑剂的制剂的药物释放百分比。由此得出的结论是,与传统方法(命中和追踪方法)相比,QbD是一种经济,快速地获得优化配方的非常有用的方法。影片的未来应用将涉及急性偏头痛的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号